Molecular Biology of Hemorrhagic Shock
Molecular Biology of Hemorrhagic Shock
批准号:
8522286
负责人:
TIMOTHY R BILLIAR
金额:
$115.09万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-06-01 至 2014-06-30
关键词:
AgeAnimal ModelApplications GrantsCause of DeathClinicalClinical DataClinical TrialsCollaborationsCommunicationConfocal MicroscopyCountryCraniocerebral TraumaDataElectron MicroscopyEventFailureFunctional disorderFundingGenerationsGoalsHMGB1 ProteinHemorrhageHemorrhagic ShockHepaticHuman ResourcesImageImmune System DiseasesImmune responseImmune systemImmunohistochemistryIn Situ HybridizationIndividualInflammatoryInflammatory ResponseInjuryIntestinal MotilityLeadLigandsLinkMediator of activation proteinModelingMolecularMolecular BiologyMorbidity - disease rateMorphologyMotorMucous MembraneMultiple Organ FailureMusNuclear ProteinOrganOutcomePathway interactionsPatientsPatternPattern recognition receptorPredispositionProcessProtocols documentationRelianceResearchResearch PersonnelRoleSepsisSeriesShockSideSignal TransductionSimulateSourceStressSupervisionTLR2 geneTLR4 geneTestingTissuesToll-like receptorsTraumaTraumatic ShockUp-RegulationValidationanimal tissuebaseexperiencemathematical modelmicrobialmortalitynovelresponseresponse to injurytissue trauma
中文摘要
在这个国家,创伤是54岁以下人群死亡的主要原因。除了严重的头部损伤外,出血/组织创伤及其后果是这些通常是年轻的、其他方面健康的人发病和死亡的最重要原因。这项中心拨款提案旨在促进我们对创伤和出血后导致器官损伤和功能障碍的分子机制的理解。我们的重点是导致炎症反应的激活和传播的事件,认为炎症反应的大小是损伤后早期器官损伤/功能障碍和迟发性免疫功能障碍的主要决定因素。因此,了解激发事件可以导致有效的方法,不仅限制早期器官损害,而且还可以限制晚期脓毒症和多器官衰竭(MOF)的易感性。
我们认为,理解失血性休克引起的器官损伤的关键之一是表征导致创伤事件后炎症变化的启动和传播的最早的分子事件。从以前的资金周期中,我们知道炎症和应激信号的启动在休克诱导后很快发生,这些反应的放大涉及一系列重叠的事件。我们最近对识别近端步骤的努力提供了令人信服的证据,表明先天免疫系统的模式识别受体(Toll样受体)在损伤后早期参与,并启动和驱动炎症反应。TLR4和TLR9是激活炎症信号所必需的,而TLR2和TLR4明显不受调控,如果由微生物配体触发,可以诱导过度的炎症反应。我们PI的数据表明TLR2和TLR9的组织特异性表达和功能模式。TLR信号的内源性激活物,称为损伤相关分子模式(DAMP)分子,似乎驱动TLR4和TLR9的初始激活。核蛋白高迁移率族蛋白-1(HMGB1)显然参与了这一过程,并在我们的创伤模型中作为一个典型的潮湿的例子。因此,以DAMP-PRR相互作用为例的危险信号代表了损伤后免疫系统激活的范例。许多下游信号和器官反应都是在这些启动事件的下游进行的。事实证明,我们的机制驱动的方法有助于确定一些关键的途径和介体。然而,随着信息量的扩大,我们已经认识到有必要通过一系列预测关键事件之间关系的数学模型来整合这些信息。这些模型的不断完善将来自于纳入新的实验数据并在临床环境中验证实验数据。最终,这些模型将指导新假说的产生。
正如创伤和休克的早期分子信号事件是高度整合的一样,我们的研究方法也是如此。这五个项目中的每个项目都追求东道主对创伤和休克的特定方面的反应。所有这些项目都是通过建立良好的合作渠道并共同依赖三个组织良好的核心进行整合的。项目I(Billiar)致力于研究全身和肝脏炎症反应的激活机制,强调TLR4、TLR9和HMGB1的作用。项目II(Hackam)探讨了TLR4和TLR9在Gl粘膜功能障碍和损伤中的作用。项目III(Bauer)研究了导致肠道运动功能衰竭的介质。该项目探讨了TLR2上调对肠道动力变化的影响。项目IV(FAN)研究了导致损伤后炎症小体激活的途径,特别强调了TLR4和HMGB1在这一过程中的作用。项目V(Vodovotz/Ochoa)将实验结果整合到伤害反应的数学模型中。项目V还通过收集创伤患者的临床数据将项目L-VI与临床方面联系起来,将其纳入我们最具翻译性的数学模型,该模型用于有前景的疗法的模拟临床试验以及特定患者的结果预测。
通过三个组织良好的核心的共同使用,这些合作和中心的总体目标将得到显着促进。动物模型核心(核心B)将在技术经验丰富的核心人员的监督下,提供符合失血性休克和出血合并组织创伤标准化方案的动物(主要是小鼠)的组织来源。这种方法保持了项目之间模型的一致性,并允许对结果进行详细比较。结构成像核心(核心C)将在最先进的组织成像方面提供非凡的专业知识,包括免疫组织化学、共聚焦显微镜、电子显微镜、定量形态学和原位杂交。由于每个项目都测试了一个单独的假说,该假说试图确定失血性或创伤性休克组织中的分子事件,因此有效和准确的结构成像来定位这些变化对每个研究人员来说都是至关重要的。行政核心(核心A)将提供确保富有成效的协作和沟通所需的关键组织。根据我们迄今取得的进展,我们完全相信,我们的做法将继续导致富有成效的合作和对新的重要假设的有效检验。
英文摘要
Trauma is the leading cause of death in this country in people under the age of 54 years. Except for major head injury, hemorrhage/tissue trauma and its consequences are the most important causes of morbidity and mortality in these often young, otherwise healthy individuals. This Center Grant proposal seeks to advance our understanding of the molecular mechanisms leading to organ injury and dysfunction following trauma and hemorrhage. Our focus is on the events leading to the activation and propagation of inflammatory response with the view that the magnitude of the inflammatory response is the primary determinant of both early organ damage/dysfunction and delayed immune dysfunction following injury. Thus, understanding the inciting events could lead to effective approaches to limit not only the early organ damage but also the susceptibility to late sepsis and multiple organ failure (MOF).
We propose that one of the keys to understanding organ injury resulting from hemorrhagic shock is to characterize the earliest molecular events leading to the initiation and propagation of inflammatory changes following the traumatic event. From previous funding cycles, we know that the initiation of inflammatory and stress signaling occurs quickly after the induction of shock and that the amplification of these responses involves a series of overlapping events. Our most recent efforts to identify the proximal steps have provided compelling evidence that pattern recognition receptors (PRR) of the innate immune system (Toll-like receptors) are engaged early following injury and both initiate and drive the inflammatory response. TLR4 and TLR9 are required for the activation of inflammatory signaling, while TLR2 and TLR4 are markedly unregulated and can induce an exaggerated inflammatory response if triggered by microbial ligands. Data from our PI's indicate tissue-specific expression and function patterns for TLR2 and TLR9. Endogenous activators of TLR signaling known as Damage-Associated Molecular Pattern (DAMP) molecules appear to drive the initial activation of TLR4 and TLR9. The nuclear protein high mobility group box-1 (HMGB1) is clearly involved in this process, and serves as an example of a prototypic DAMP in our trauma models. Thus, the danger signaling exemplified by the DAMP-PRR interaction represents a paradigm for the activation of the immune system post-injury. Much of the downstream signaling and organ response follows downstream from these initiating events. Our mechanism-driven approach has proven useful to identify some of the key pathways and mediators. However, as the quantity of information has expanded, we have recognized the need to integrate this information via a series of mathematical models that predict the relationship among key events. Constant refinement of these models will come from the incorporation of new experimental data and validation of experimental data in the clinical setting. Ultimately, these models guide the generation of new hypotheses.
Just as the early molecular signaling events in trauma and shock are highly integrated, so is our research approach. Each of the five projects pursues a defined aspect of the host response to trauma and shock. All of the projects are integrated through well-established collaborative channels and co-reliance on three well-organized cores. Project I (Billiar) pursues the mechanisms involved in the activation of the systemic and hepatic inflammatory response emphasizing the roles of TLR4, TLR9, and HMGB1. Project II (Hackam) explores the roles of TLR4 and TLR9 in the dysfunction and damage to the Gl mucosa. Project III (Bauer) studies the mediators leading to gut motor function failure. This project explores the consequences of TLR2 upregulation on intestinal motility changes. Project IV (Fan) examines the pathways leading to the activation of the inflammasome post-injury, with a particular emphasis on TLR4 and HMGB1 in this process. Project V (Vodovotz/Ochoa) integrates the experimental findings into mathematical models of the injury response. Project V also links projects l-VI with the clinical side by gathering clinical data on trauma patients for incorporation into our most translational mathematical model, used for simulated clinical trials of promising therapies as well as for patient-specific outcome prediction.
These collaborations and the overall goal of the center will be promoted significantly by the common use of three well-organized cores. The Animal Models Core (Core B) will provide a source of tissues from animals (primarily mice) subjected to standardized protocols of hemorrhagic shock and hemorrhage with tissue trauma under the supervision of technically experienced core personnel. This approach maintains consistency of the models between the projects and permits a detailed comparison of results. The Structural Imaging Core (Core C) will provide extraordinary expertise in state-of-the-art tissue imaging, including immunohistochemistry, confocal microscopy, electron microscopy, quantitative morphology, and in situ hybridization. Since each of the projects tests an individual hypothesis that seeks to identify the molecular events in tissues in hemorrhagic or traumatic shock, efficient and accurate structural imaging to localize these changes is essential to each investigator. The Administrative Core (Core A) will provide the critical organization needed to assure productive collaboration and communication. Based on our progress thus far, we are fully confident that our approach will continue to lead to productive collaboration and effective testing of a novel and important hypotheses.
期刊论文(256)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.pmrj.2013.10.006
发表时间:
2014-04
期刊:
PM & R : the journal of injury, function, and rehabilitation
影响因子:
--
作者:
[Huang W, Vodovotz Y, Kusturiss MB, Barclay D, Greenwald K, Boninger ML, Coen PM, Brienza D, Sowa G]
通讯作者:
Sowa G
DOI:
10.4049/jimmunol.182.1.572
发表时间:
2009-01-01
期刊:
JOURNAL OF IMMUNOLOGY
影响因子:
4.4
作者:
[Liu, Yujian, Yuan, Youzhong, Li, Yuehua, Zhang, Jian, Xiao, Guozhi, Vodovotz, Yoram, Billiar, Timothy R., Wilson, Mark A., Fan, Jie]
通讯作者:
Fan, Jie
DOI:
10.1513/pats.200501-007ac
发表时间:
2005-01-01
期刊:
Proceedings of the American Thoracic Society
影响因子:
--
作者:
[St Croix, Claudette M, Leelavaninchkul, Karanee, Pitt, Bruce R]
通讯作者:
Pitt, Bruce R
DOI:
10.4049/jimmunol.1402490
发表时间:
2015-05-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Sodhi CP, Jia H, Yamaguchi Y, Lu P, Good M, Egan C, Ozolek J, Zhu X, Billiar TR, Hackam DJ]
通讯作者:
Hackam DJ
DOI:
10.1016/j.jss.2011.12.015
发表时间:
2012-11
期刊:
The Journal of surgical research
影响因子:
--
作者:
[Gómez H, Mesquida J, Hermus L, Polanco P, Kim HK, Zenker S, Torres A, Namas R, Vodovotz Y, Clermont G, Puyana JC, Pinsky MR]
通讯作者:
Pinsky MR
共 118 条
Mechanisms of Immune Dysfunction after Trauma and Surgical Sepsis
-
批准号:10183268
-
项目类别:
-
资助金额:$63.28万
-
财政年份:2018
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
Mechanisms of Immune Dysfunction after Trauma and Surgical Sepsis
-
批准号:10623487
-
项目类别:
-
资助金额:$69.72万
-
财政年份:2018
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
Mechanisms of Immune Dysfunction after Trauma and Surgical Sepsis
-
批准号:10403953
-
项目类别:
-
资助金额:$63.28万
-
财政年份:2018
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
Immunometabolism in Sepsis
-
批准号:9110280
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2015
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
Immunometabolism in Sepsis
-
批准号:9274994
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2015
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
Immunometabolism in Sepsis
-
批准号:8937151
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2015
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
Core A: Administrative Core
-
批准号:7751473
-
项目类别:
-
资助金额:$3.83万
-
财政年份:2009
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
Project 1: Initiation of Inflammation in Hemorrhagic Shock
-
批准号:7751460
-
项目类别:
-
资助金额:$25.71万
-
财政年份:2009
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
Core B: Animal Models Core
-
批准号:7751475
-
项目类别:
-
资助金额:$29.23万
-
财政年份:2009
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
Trauma and Injury Excellence in Education on Research (TralnEER) Program
-
批准号:7216886
-
项目类别:
-
资助金额:$14.47万
-
财政年份:2006
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
Trauma and Injury Excellence in Education on Research (TralnEER) Program
-
批准号:7585779
-
项目类别:
-
资助金额:$14.47万
-
财政年份:2006
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
Trauma and Injury Excellence in Education on Research (TralnEER) Program
-
批准号:7117070
-
项目类别:
-
资助金额:$16.59万
-
财政年份:2006
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
iNOS Gene Therapy to Prevent Allograft Vasculopathy
-
批准号:7139403
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2005
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
CORE--ANIMAL MODEL FACILITY/Core B
-
批准号:6829219
-
项目类别:
-
资助金额:$23.68万
-
财政年份:2004
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
INITIATION OF INFLAMMATION IN HEMORRHAGIC SHOCK
-
批准号:6829215
-
项目类别:
-
资助金额:$22.21万
-
财政年份:2004
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:6861606
-
项目类别:
-
资助金额:$4.03万
-
财政年份:2004
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
CD14 AND INFLAMMATION IN HEMORRHAGIC SHOCK
-
批准号:6107772
-
项目类别:
-
资助金额:$11.19万
-
财政年份:1999
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
CORE--ANIMAL MODELS FACILITY
-
批准号:6107777
-
项目类别:
-
资助金额:$11.19万
-
财政年份:1999
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
CD14 AND INFLAMMATION IN HEMORRHAGIC SHOCK
-
批准号:6271865
-
项目类别:
-
资助金额:$10.87万
-
财政年份:1998
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
Molecular Biology of Hemorrhagic Shock
-
批准号:7694077
-
项目类别:
-
资助金额:$153.1万
-
财政年份:1998
-
负责人:TIMOTHY R BILLIAR
-
依托单位:
海外基金